Filing Details
- Accession Number:
- 0000899243-23-010004
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-03-29 21:11:04
- Reporting Period:
- 2023-03-27
- Accepted Time:
- 2023-03-29 21:11:04
- Original Submission Date:
- 2023-03-29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610676 | Anne Mary Heino | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-27 | 44,484 | $19.11 | 463,881 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-27 | 28,662 | $80.47 | 435,219 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-27 | 15,822 | $81.30 | 419,397 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2023-03-27 | 44,484 | $0.00 | 44,484 | $19.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-04-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 300,000 | Indirect | By Grantor Retained Annuity Trust |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 24, 2023.
- On March 10, 2023, the reporting person transferred 300,000 shares of LNTH common stock to a Grantor Retained Annuity Trust of which the reporting person's spouse is a trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust.
- The Form 4 originally filed on March 29, 2023 inadvertently identified shares as Indirect Ownership due to an administrative error.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.89 to $80.88, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.89 to $81.838, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
- 100% of the shares subject to the option are fully vested and exercisable.
Billionaire Hedge Funds
